24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
NovaQuest
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
19:28
Full list of Israeli high-tech funding rounds in 2024
19:24
TailorMed raises $40 million in equity and debt to help patients access critical medications
18:17
Why Israeli tech companies are moving to Miami
17:11
Mediaocean acquires Innovid for $500M, delisting it from the NYSE
More stories
Buzz
Most popular
Daily
Weekly
1
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
2
Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months
3
Claroty veterans launch Twine with $12M in Seed funding from Dell and Wiz founders to deploy AI cyber workers
4
Mediaocean acquires Innovid for $500M, delisting it from the NYSE
5
Prompt Security raises $18 million Series A to protect enterprises from GenAI risks
More news
NovaQuest
1 stories about NovaQuest
The Israeli startup combating drug-resistant bacteria
24.10.21
|
Yafit Ovadia
“Some 70% of antibiotics worldwide are administered to animals, and affected pathogens may later develop antimicrobial resistance and enter the environment, affecting humans,” says David Javier Iscovich, the CEO of Mileutis, which has developed an antibiotic-alternative for dairy cows and animal health
Please ensure Javascript is enabled for purposes of
website accessibility
